Hongdan Chen

Dr. Hongdan Chen


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2022 in Langenbeck's Archives of Surgery
Verified
Journal Article
Closed access
PDF file
MTMi Tang
Mi Tang
SYSupeng Yin
Supeng Yin
ZYZeyu Yang
Zeyu Yang
YSYiceng Sun
Yiceng Sun
HCHongdan Chen
Hongdan Chen
FZFan Zhang
Fan Zhang

19 January 2022 in Breast Cancer
Verified
Journal Article
Closed access
PDF file
ZYZe-Yu Yang
Ze-Yu Yang
SYSu-Peng Yin
Su-Peng Yin
QRQingnan Ren
Qingnan Ren
DLDeng-Wei Lu
Deng-Wei Lu
TTTao Tang
Tao Tang
HCHongdan Chen
Hongdan Chen

23 April 2019 in Current Medical Science
Verified
Journal Article
Closed access
PDF file
HCHongdan Chen
Hongdan Chen
YCYi-Ping Chen
Yi-Ping Chen
RXRui Xie
Rui Xie
QHQin-Yu Hu
Qin-Yu Hu
QCQi Cheng
Qi Cheng
MXMing Xiang
Ming Xiang

2 February 2024 in Innovative Surgical Sciences
Verified
Journal Article
Open access
PDF file
HCHongdan Chen
Hongdan Chen
YSYicheng Sun
Yicheng Sun
MTMi Tang
Mi Tang
FZFan Zhang
Fan Zhang
Objectives: Horner syndrome (HS) is a rare complication of thyroid surgery. However, the relationship between the occurrence of HS and thyroid upper pole injury is still not completely clear, and there are only few reports. Case presentation: A 24-year-old female underwent endoscopic thyroidectomy for thyroid papillary carcinoma. The intraoperative examination found that the upper pole of the thyroid was bleeding. During hemostasis, the ultrasonic knife consciously peeled too deep and stopped. The patient developed HS immediately after operation. We analyzed the association between deep dissection of the upper thyroid pole and an increase in the HS incidence rate through literature searches and anatomical relationships. Conclusions: Our case report discussed the potential relationship between the degree of thyroid upper pole dissection and the occurrence of HS in routine thyroid surgery, and provided a warning for the degree of thyroid upper pole dissection in the clinic to avoid HS.

1 July 2025 in Journal of Zhejiang University (Medical Sciences)
Verified
Journal Article
Open access
PDF file
HCHongdan Chen
Hongdan Chen
LZLong Zhang
Long Zhang
LCLi Chong
Li Chong
The tumor microenvironment (TME) is a critical determinant of tumor initiation, progression, and therapeutic response. Its marked heterogeneity underscores the need for a more comprehensive understanding of its composition and function. In addition to the extensively studied "classical" TME, emerging evidence highlights the significant roles of the tumor mechanical microenvironment and the tumor microbial microenvironment in modulating treatment efficacy. These non-classical dimensions not only independently influence tumor behavior but also interact dynamically with classical TME components. Mechanical cues within the TME, including matrix stiffness and solid stress, significantly affect drug distribution and treatment efficacy, suggesting that mechanical remodeling represents a potential strategy to enhance therapeutic outcomes. Concurrently, tumor-associated microbiota and their metabolites participate in immune regulation and metabolic reprogramming, contributing to tumor development and offering novel therapeutic targets. Moreover, recent advances have broadened our understanding of the multilayered regulatory landscape of the TME through the investigation of previously underappreciated factors such as neural regulation, metabolic niche dynamics, spatiotem-poral heterogeneity, and epigenetic modulation. This review systematically summarizes the characteristics of these diverse TME dimensions and explores their integration with precision drug delivery strategies. We highlight recent progress in therapeutic interventions targeting the classical TME, mechanical forces, and microbiota-related pathways, and propose interdisciplinary approaches aimed at facilitating the development of more personalized and effective anticancer therapies.

16 September 2022 in Breast Cancer
Verified
Journal Article
Closed access
PDF file
ZYZe-Yu Yang
Ze-Yu Yang
SYSu-Peng Yin
Su-Peng Yin
QRQingnan Ren
Qingnan Ren
DLDeng-Wei Lu
Deng-Wei Lu
TTTao Tang
Tao Tang
HCHongdan Chen
Hongdan Chen